NASDAQ
BioCryst Pharmaceuticals, Inc. (BCRX) has a fcf yield of 20.00% as of Friday, May 29, 2026. This represents a 415.63% increase compared to its 12-month average of -6.34%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.